Table 2.
Optimal dose of epigenetic modifiers used.
| Drug name | Optimal concentration |
|---|---|
| TWS119 | 3.5 µM |
| DOT1L inhibitor SGC0946 | 2.5 µM |
| Vorinostat | 2.5 µM |
| Panobinostat | – |
| JQ1 | 8 µM |
| GSK343 | 6 µM |
| GSKJ4 | 2.5 µM |
| GSK2801 | – |
| IBET | 3 µM |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.